The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2026

Filed:

Apr. 18, 2025
Applicant:

City of Hope, Duarte, CA (US);

Inventors:

Don J. Diamond, Glendora, CA (US);

Felix Wussow, Glendora, CA (US);

Flavia Chiuppesi, Duarte, CA (US);

Assignee:

CITY OF HOPE, Duarte, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); A61K 39/00 (2006.01); A61K 39/215 (2006.01); A61P 31/14 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 39/215 (2013.01); A61P 31/14 (2018.01); C07K 14/005 (2013.01); A61K 2039/53 (2013.01); A61K 2039/575 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24171 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/20071 (2013.01);
Abstract

Synthetic MVA-based vaccine compositions for preventing or treating a virus infection such as a coronavirus infection and methods of producing the vaccines. The vaccine compositions include (i) either a single DNA fragment that includes the entire genome of MVA, or two or more DNA fragments, each including a partial sequence of the genome of the MVA such that the two or more DNA fragments, when expressed in the host cell upon co-transfection, are assembled sequentially and comprise the full-length sequence of the MVA genome, and (ii) one or more DNA sequences encoding one or more human coronavirus antigens, subunits, or fragments thereof inserted in one or more insertion sites of the MVA. The antigens, subunits, or fragments thereof are expressed in the host cell upon transfection of the one or more DNA fragments.


Find Patent Forward Citations

Loading…